Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Children
Clinical trial NCT00502593 · COMPLETED
Trial details
- NCT number
- NCT00502593
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-23
- Primary completion
- 2009-12-04
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.